Daphne W Bell

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Endometrial Cancer

Bioinformatics Analysis

Top Venues

Nature reviews. Cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Meghan L Rudd, Nancy F Hansen, Xiaolu Zhang, Mary Ellen Urick, Suiyuan Zhang, Maria J Merino, null null, May Christine V Malicdan, Lawrence C Brody, Daphne W Bell
KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas. PloS one 17 (1) (2022)
Mary Ellen Urick, Eun-Jeong Yu, Daphne W Bell
High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels. Cancer 127 (16) (2021)
Mary Ellen Urick, Eun-Jeong Yu, Daphne W Bell
Reply to FBXW7, L1CAM, and TGM2 in endometrial cancer. Cancer 127 (21) (2021)
Mary Ellen Urick, Daphne W Bell
Proteomic profiling of FBXW7-mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target. Cancer medicine 9 (11) (2020)
Mary Ellen Urick, Daphne W Bell
Clinical actionability of molecular targets in endometrial cancer. Nature reviews. Cancer 19 (9) (2019)
Matthieu Le Gallo, Meghan L Rudd, Mary Ellen Urick, Nancy F Hansen, null null, Maria J Merino, David G Mutch, Paul J Goodfellow, James C Mullikin, Daphne W Bell
The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas. Cancer 124 (1) (2017)
Matthieu Le Gallo, Meghan L Rudd, Mary Ellen Urick, Nancy F Hansen, Suiyuan Zhang, null null, Fred Lozy, Dennis C Sgroi, August Vidal Bel, Xavier Matias-Guiu, Russell R Broaddus, Karen H Lu, Douglas A Levine, David G Mutch, Paul J Goodfellow, Helga B Salvesen, James C Mullikin, Daphne W Bell
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing. Cancer 123 (17) (2017)